Cargando…
T cell immunoglobulin and mucin domain‐containing molecule 3 on CD14(+) monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes mellitus
AIMS/INTRODUCTION: Type 2 diabetes is a worldwide disease that is associated with increased rates of obesity and reduced physical activity. Obesity‐associated insulin resistance in type 2 diabetes is a disorder in the balance between pro‐inflammatory and anti‐inflammatory signals. T cell immunoglobu...
Autores principales: | Yan, Wen‐jiang, Sun, Peng, Wei, Dan‐dan, Wang, Shuang‐xi, Yang, Jing‐jing, Li, Yi‐hui, Zhang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089949/ https://www.ncbi.nlm.nih.gov/pubmed/27182056 http://dx.doi.org/10.1111/jdi.12523 |
Ejemplares similares
-
Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus
por: Asano, Tomoyuki, et al.
Publicado: (2020) -
Expression of T-cell Immunoglobulin- and Mucin-domain-containing Molecule-3 on Lymphocytes from Henoch-Schoenlein Purpura Patients
por: Yuan, Li-ping, et al.
Publicado: (2013) -
Association of T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (Tim-3) Polymorphisms with Susceptibility and Disease Progression of HBV Infection
por: Liao, Jingyu, et al.
Publicado: (2014) -
Epigenetic Profiles Reveal That ADCYAP1 Serves as Key Molecule in Gestational Diabetes Mellitus
por: Li, Xue, et al.
Publicado: (2019) -
T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management
por: Yoneda, Akihiro, et al.
Publicado: (2013)